These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34126087)
1. Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. Hariton E; Shirazi TN; Douglas NC; Hershlag A; Briggs SF Am J Obstet Gynecol; 2021 Nov; 225(5):515.e1-515.e10. PubMed ID: 34126087 [TBL] [Abstract][Full Text] [Related]
2. Ovarian reserve markers in women using various hormonal contraceptives. Landersoe SK; Forman JL; Birch Petersen K; Larsen EC; Nøhr B; Hvidman HW; Nielsen HS; Nyboe Andersen A Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):65-71. PubMed ID: 31852271 [No Abstract] [Full Text] [Related]
3. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women. Nelson SM; Ewing BJ; Gromski PS; Briggs SF Fertil Steril; 2023 Jun; 119(6):1069-1077. PubMed ID: 36801456 [TBL] [Abstract][Full Text] [Related]
4. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148 [TBL] [Abstract][Full Text] [Related]
5. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels. Bernardi LA; Weiss MS; Waldo A; Harmon Q; Carnethon MR; Baird DD; Wise LA; Marsh EE Fertil Steril; 2021 Jul; 116(1):208-217. PubMed ID: 33752880 [TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740 [TBL] [Abstract][Full Text] [Related]
7. Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women. Hawkins Bressler L; Bernardi LA; De Chavez PJ; Baird DD; Carnethon MR; Marsh EE Am J Obstet Gynecol; 2016 Dec; 215(6):758.e1-758.e9. PubMed ID: 27418446 [TBL] [Abstract][Full Text] [Related]
8. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858 [TBL] [Abstract][Full Text] [Related]
9. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091 [TBL] [Abstract][Full Text] [Related]
10. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility. Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431 [TBL] [Abstract][Full Text] [Related]
11. Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives. Li HW; Wong CY; Yeung WS; Ho PC; Ng EH Contraception; 2011 Jun; 83(6):582-5. PubMed ID: 21570558 [TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Somunkiran A; Yavuz T; Yucel O; Ozdemir I Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955 [TBL] [Abstract][Full Text] [Related]
13. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961 [TBL] [Abstract][Full Text] [Related]
14. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991 [TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA; Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481 [TBL] [Abstract][Full Text] [Related]
16. Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion. Kucera R; Ulcova-Gallova Z; Topolcan O Gynecol Endocrinol; 2016; 32(5):383-5. PubMed ID: 26651155 [TBL] [Abstract][Full Text] [Related]
17. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome. Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776 [TBL] [Abstract][Full Text] [Related]